172 related articles for article (PubMed ID: 37896899)
61. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting FGFR2.
Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195
[TBL] [Abstract][Full Text] [Related]
62. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
Lv M; Zhang X; Li M; Chen Q; Ye M; Liang W; Ding L; Cai H; Fu D; Lv Z
PLoS One; 2013; 8(7):e67591. PubMed ID: 23861775
[TBL] [Abstract][Full Text] [Related]
63. miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma.
Minna E; Romeo P; De Cecco L; Dugo M; Cassinelli G; Pilotti S; Degl'Innocenti D; Lanzi C; Casalini P; Pierotti MA; Greco A; Borrello MG
Oncotarget; 2014 May; 5(9):2513-28. PubMed ID: 24810336
[TBL] [Abstract][Full Text] [Related]
64. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway.
Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X
Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303
[TBL] [Abstract][Full Text] [Related]
65. The stress-activated protein kinase pathway and the expression of stanniocalcin-1 are regulated by miR-146b-5p in papillary thyroid carcinogenesis.
Al-Abdallah A; Jahanbani I; Mehdawi H; Ali RH; Al-Brahim N; Mojiminiyi O
Cancer Biol Ther; 2020 May; 21(5):412-423. PubMed ID: 32037949
[TBL] [Abstract][Full Text] [Related]
66. Differential proteomic and phenotypic behaviour of papillary and anaplastic thyroid cell lines.
Musso R; Di Cara G; Albanese NN; Marabeti MR; Cancemi P; Martini D; Orsini E; Giordano C; Pucci-Minafra I
J Proteomics; 2013 Sep; 90():115-25. PubMed ID: 23385357
[TBL] [Abstract][Full Text] [Related]
67. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
68. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.
Ma S; Jia W; Ni S
Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661
[TBL] [Abstract][Full Text] [Related]
69. Human herpesvirus 6A active infection in patients with autoimmune Hashimoto's thyroiditis.
Seyyedi N; Dehbidi GR; Karimi M; Asgari A; Esmaeili B; Zare F; Farhadi A; Dabbaghmanesh MH; Saki F; Behzad-Behbahani A
Braz J Infect Dis; 2019; 23(6):435-440. PubMed ID: 31751524
[TBL] [Abstract][Full Text] [Related]
70. mRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switch.
Hébrant A; Dom G; Dewaele M; Andry G; Trésallet C; Leteurtre E; Dumont JE; Maenhaut C
PLoS One; 2012; 7(10):e37807. PubMed ID: 23115614
[TBL] [Abstract][Full Text] [Related]
71. MiR-145 functions as a tumor suppressor in Papillary Thyroid Cancer by inhibiting RAB5C.
Zhang W; Ji W; Li T; Liu T; Zhao X
Int J Med Sci; 2020; 17(13):1992-2001. PubMed ID: 32788878
[TBL] [Abstract][Full Text] [Related]
72. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma.
Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y
Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940
[TBL] [Abstract][Full Text] [Related]
73. miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and ERBB4.
Nie FR; Li QX; Wei HF; Ma Y
Neoplasma; 2020 May; 67(3):604-613. PubMed ID: 32266816
[TBL] [Abstract][Full Text] [Related]
74. Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression.
Wei H; Pan L; Tao D; Li R
Biochem Biophys Res Commun; 2018 Sep; 503(1):56-61. PubMed ID: 29842886
[TBL] [Abstract][Full Text] [Related]
75. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
[TBL] [Abstract][Full Text] [Related]
76. miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6.
Wen Q; Zhao J; Bai L; Wang T; Zhang H; Ma Q
Oncol Rep; 2015 Oct; 34(4):2202-10. PubMed ID: 26239517
[TBL] [Abstract][Full Text] [Related]
77. The anti-cancer role of microRNA-143 in papillary thyroid carcinoma by targeting high mobility group AT-hook 2.
Ding C; Shi T; Wu G; Man J; Han H; Cui Y
Bioengineered; 2022 Mar; 13(3):6629-6640. PubMed ID: 35213273
[TBL] [Abstract][Full Text] [Related]
78. Hypoxic papillary thyroid carcinoma cells-secreted exosomes deliver miR-221-3p to normoxic tumor cells to elicit a pro-tumoral effect by regulating the ZFAND5.
Yu F; Deng X; Zhong Y; Guo B; Zhang X; Wu B
Exp Cell Res; 2023 Oct; 431(1):113716. PubMed ID: 37488006
[TBL] [Abstract][Full Text] [Related]
79. MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.
Qiu W; Yang Z; Fan Y; Zheng Q
Oncotarget; 2016 Jun; 7(26):39907-39915. PubMed ID: 27223438
[TBL] [Abstract][Full Text] [Related]
80. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]